Biopsy Needle Market Share Analysis | Global Statistics - 2032

Biopsy Needle Market Size - Product (Needle Based Biopsy Guns, Biopsy Needles), By Application (Cancer/Tumor {Breast, Lung, Prostate, Colon, Stomach, Liver, Cervix uteri}, Infectious Diseases, Autoimmune Disorder), By End-use & Forecast, 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.2.1&nbsp;&nbsp;&nbsp; North America

1.2.2&nbsp;&nbsp;&nbsp; Europe

1.2.3&nbsp;&nbsp;&nbsp; Asia Pacific

1.2.4&nbsp;&nbsp;&nbsp; Latin America

1.2.5&nbsp;&nbsp;&nbsp; MEA

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data validation

1.5&nbsp;&nbsp;&nbsp; Data sources

1.5.1&nbsp;&nbsp;&nbsp; Secondary

1.5.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.5.1.2&nbsp;&nbsp;&nbsp;Unpaid sources

1.5.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Biopsy needle market industry 3600&nbsp;synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Biopsy Needle Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2.1&nbsp;&nbsp;&nbsp; Vendor Matrix

3.2.2&nbsp;&nbsp;&nbsp; Distribution channel analysis

3.2.3&nbsp;&nbsp;&nbsp; Profit margin trends

3.3&nbsp;&nbsp;&nbsp; Raw material analysis

3.2.1&nbsp;&nbsp;&nbsp; Nanomaterials

3.2.2&nbsp;&nbsp;&nbsp; Polymers

3.2.3&nbsp;&nbsp;&nbsp; Semiconductors

3.2.4&nbsp;&nbsp;&nbsp; Others

3.3&nbsp;&nbsp;&nbsp; Pricing analysis 2018 &ndash; 2032

3.3.1&nbsp;&nbsp;&nbsp; Pricing analysis, by region

3.3.1.1&nbsp;&nbsp;&nbsp;North America

3.3.1.2&nbsp;&nbsp;&nbsp;Europe

3.3.1.3&nbsp;&nbsp;&nbsp;Asia Pacific

3.3.1.4&nbsp;&nbsp;&nbsp;Latin America

3.3.1.5&nbsp;&nbsp;&nbsp;Middle East &amp; Africa

3.4&nbsp;&nbsp;&nbsp; Cost structure analysis

3.4.1&nbsp;&nbsp;&nbsp; Component/material costs

3.4.2&nbsp;&nbsp;&nbsp; Manufacturing &amp; labour costs

3.4.3&nbsp;&nbsp;&nbsp; Utilities

3.4.4&nbsp;&nbsp;&nbsp; Maintenance cost

3.4.5&nbsp;&nbsp;&nbsp; Finance cost

3.4.6&nbsp;&nbsp;&nbsp; Administration cost

3.4.7&nbsp;&nbsp;&nbsp; Others

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Rising incidence of cancer across the globe

3.5.1.2&nbsp;&nbsp;&nbsp;Technological advancements in biopsy needles

3.5.1.3&nbsp;&nbsp;&nbsp;Favorable reimbursement scenario

3.5.1.4&nbsp;&nbsp;&nbsp;Increasing awareness regarding breast cancer

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;Risk of complications after biopsy

3.5.2.2&nbsp;&nbsp;&nbsp;Dearth of skilled healthcare professionals

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By product

3.6.2&nbsp;&nbsp;&nbsp; By application

3.6.3&nbsp;&nbsp;&nbsp; By end-use

3.7&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.8&nbsp;&nbsp;&nbsp; Regulatory landscape

3.8.1&nbsp;&nbsp;&nbsp; U.S.

3.8.2&nbsp;&nbsp;&nbsp; Europe

3.9&nbsp;&nbsp;&nbsp; Application landscape

3.10&nbsp;&nbsp;&nbsp; Industry eco-system

3.10.1&nbsp;&nbsp;&nbsp; Current trends in the industry

3.10.2&nbsp;&nbsp;&nbsp; Start-up scenario

3.11&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.11.1&nbsp;&nbsp;&nbsp; Bargaining power of suppliers

3.11.2&nbsp;&nbsp;&nbsp; Bargaining power of buyers

3.11.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.11.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.11.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.12&nbsp;&nbsp;&nbsp; PESTEL analysis

3.12.1&nbsp;&nbsp;&nbsp; Political

3.12.2&nbsp;&nbsp;&nbsp; Economical

3.12.3&nbsp;&nbsp;&nbsp; Social

3.12.4&nbsp;&nbsp;&nbsp; Technological

3.12.5&nbsp;&nbsp;&nbsp; Environmental

3.12.6&nbsp;&nbsp;&nbsp; Legal

Chapter 4&nbsp;&nbsp;&nbsp;Competitive landscape

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share, 2021

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Biopsy Needle Market, By Product

5.1&nbsp;&nbsp;&nbsp; Key product trends

5.2&nbsp;&nbsp;&nbsp; Needle based biopsy guns

5.2.1&nbsp;&nbsp;&nbsp; Vacuum-assisted biopsy (VAB) devices

5.2.2&nbsp;&nbsp;&nbsp; Fine needle aspiration biopsy (FNAB) devices

5.2.3&nbsp;&nbsp;&nbsp; Core needle biopsy (CNB) devices

5.3&nbsp;&nbsp;&nbsp; Biopsy needles

5.3.1&nbsp;&nbsp;&nbsp; Disposable

5.3.2&nbsp;&nbsp;&nbsp; Reusable&nbsp;&nbsp;&nbsp;

Chapter 6&nbsp;&nbsp;&nbsp;Biopsy Needle Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key application trends

6.2&nbsp;&nbsp;&nbsp; Cancer/tumor

6.2.1&nbsp;&nbsp;&nbsp; Breast

6.2.2&nbsp;&nbsp;&nbsp; Lung

6.2.3&nbsp;&nbsp;&nbsp; Prostate

6.2.4&nbsp;&nbsp;&nbsp; Colon

6.2.5&nbsp;&nbsp;&nbsp; Stomach

6.2.6&nbsp;&nbsp;&nbsp; Liver

6.2.7&nbsp;&nbsp;&nbsp; Rectum

6.2.8&nbsp;&nbsp;&nbsp; Cervix uteri

6.2.9&nbsp;&nbsp;&nbsp; Oesophagus

6.2.10&nbsp;&nbsp;&nbsp; Pancreas

6.2.11&nbsp;&nbsp;&nbsp; Leukaemia

6.2.12&nbsp;&nbsp;&nbsp; Other cancer

6.3&nbsp;&nbsp;&nbsp; Infectious diseases

6.4&nbsp;&nbsp;&nbsp; Autoimmune disorder

6.5&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Biopsy Needle Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key end-use trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical center

7.4&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Biopsy Needle Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

9.2&nbsp;&nbsp;&nbsp; Medtronic plc

9.3&nbsp;&nbsp;&nbsp; FUJIFILM Holdings Corporation

9.4&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company (BD)

9.5&nbsp;&nbsp;&nbsp; Cardinal Health

9.6&nbsp;&nbsp;&nbsp; Olympus Corporation

9.7&nbsp;&nbsp;&nbsp; Hologic Inc

9.8&nbsp;&nbsp;&nbsp; Argon Medical Devices, Inc

9.9&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

9.10&nbsp;&nbsp;&nbsp; Devicor Medical Products, Inc. (Danaher Corporation)

9.11&nbsp;&nbsp;&nbsp; Cook Group Incorporated

9.12&nbsp;&nbsp;&nbsp; INRAD Inc

9.13&nbsp;&nbsp;&nbsp; Stryker Corporation

&nbsp;&nbsp;&nbsp;

Biopsy Needle Market

Request Discount

Industries

Information

Link

Global Headquarters